650 Townsend St Ste 500
San Francisco, California 94103-6227
iRhythm Technologies (IRTC) is sticking with its fiscal 2023 revenue guidance of $475M to $485M. Read more about its financial outlook here.
Since SVB Financial’s (NASDAQ: SIVB ) principal subsidiary, Silicon Valley Bank, collapsed last week, Wall Street has been in turmoil. With SVB seized by government regulators and New York’s Signature Bank (NYSE: SBNY ) shut down, banking stocks have been in free fall and don’t show any signs of reversing direction. Many of the stocks that saw trading halts imposed last week as SIVB fell are still deep in the red today , while confidence in the sector continues to fall. The Federal Deposit Insurance Corporation (FDIC) is working to help individual SVB depositors recover the money they couldn’t get out during last week’s bank run. But what does that mean for the companies that had money in SVB? As it turns out, there were quite a few companies with significant deposits in the bank that no longer stands. It’s well-known that Silicon Valley Bank had strong ties to the local startup community. But its client list also included plenty of larger, publicly traded companies. Now, investors are looking for answers in the carnage of the biggest financial meltdown since 2008.
Roku, Circle, Roblox, BlockFi, Rocket Lab USA, Juniper Networks, LendingClub, Unity Software, and iRhythm Technologies had significant amounts of money deposited in Silicon Valley Bank prior to its downfall. Roku, a digital media hardware company known for its streaming devices, had about 26% of its cash—$487 million—deposited in Silicon Valley Bank Financial, according to a securities filing. Other companies, including blockchain firm Circle, video game company Roblox, and aerospace manufacturing company Rocket Lab USA, also had significant funds deposited in the bank before it collapsed due to regulatory pressures on Friday. Circle tweeted on Friday night that it had $3.3 billion deposited in the bank, while Roblox Corporation held 5% of its $3 billion in cash ($150 million) at the bank. BlockFi, the cryptocurrency exchange platform, which filed for bankruptcy in November, had $227 million in uninsured holdings at Silicon Valley Bank, according to its filing. Rocket Lab USA had […] - Top Companies with Major Funds Held in Silicon Valley Bank before its Crash - NNN - NNN - Latest News Updates Today
Additional studies presented at ACC.23/WCC reinforce the clinical value of the Zio suite of products and services SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent disease, recently presented the results of multiple new studies at the American College
Douglas Devine , Chief Operating Officer at iRhythm Technologies (NASDAQ: IRTC ), reported a large insider sell on March 1, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Devine sold 3,518 shares of iRhythm Technologies . The total transaction amounted to $414,563. iRhythm Technologies shares are trading down 0.64% at $117.37 at the time of this writing on Thursday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily to … Full story available on Benzinga.com
iRhythm continues to expand its strong body of clinical and scientific evidence with new research presented by leading clinical investigators at the conference Highlights include a retrospective analysis of comparative effectiveness between ambulatory monitors for arrhythmia diagnosis SAN FRANCISCO, March 02, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital
iRhythm Technologies Inc (NASDAQ: IRTC ) reported Q4 FY22 revenue of $112.6 million , up 37.7% Y/Y beating the consensus of $110.26 million. The company reported a net loss of $(20.2) million, a $12.3 million improvement compared to the fourth quarter of 2021. It reported an adjusted EBITDA of $1.1 million, an $18.4 million improvement compared to Q4 FY21. iRhythm Technologies sees FY23 revenues of $475-$485 million compared to the consensus of $485.6 million. Adjusted EBITDA margin is expected to … Full story available on Benzinga.com
iRhythm Technologies, Inc. (NASDAQ:NASDAQ:IRTC) Q4 2022 Earnings Conference Call February 23, 2023 4:30 PM ETCompany ParticipantsStephanie Zhadkevich - Director of Investor RelationsQuentin…
iRhythm Technologies press release (IRTC): Q4 Non-GAAP EPS of -$0.59 beats by $0.02.Revenue of $112.62M (+37.7% Y/Y) beats by $2.34M.
SAN FRANCISCO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December 31, 2022.
iRhythm Technologies (NASDAQ: IRTC ) is set to give its latest quarterly earnings report on Thursday, 2023-02-23. Here''s what investors need to know before the announcement. Analysts estimate that iRhythm Technologies will report an earnings per share (EPS) of $-0.62. iRhythm Technologies bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com
SAN FRANCISCO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2022 after the close of trading on Thursday, February 23, 2023. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT/4:30 p.m. ET.
Wells Fargo has initiated iRhythm Technologies (IRTC) with an outperform rating saying it has the potential to double its US penetration in the ambulatory cardiac monitoring market by 2027.